Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 6,726–6,750 of 7,816 matching trials · page 270 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Dementia Phenotypes in Primary Care, Hospital, and National Mortality Registries NCT02549872 This is not an intervention study Runs in: United Kingdom · 1 site |
NA other |
UNKNOWN | 51,000 | University College, London OTHER |
2015-09-15 |
|
MoCa Test for the Early Detection of Mild Cognitive Impairment During Annual Assessment of Young Adults With Diabetes and in a Control Group Without Diabetes NCT02545062 MoCa test Runs in: Israel · 1 site |
NA other |
UNKNOWN | 170 | Clalit Health Services OTHER |
2015-09-11 |
|
Assessment of Social-emotional Functioning in Neurological Diseases NCT01339130 Computerized tests and Electrophysiological measurements Runs in: France · 1 site |
NA other |
COMPLETED | 177 | Centre Hospitalier Universitaire, Amiens OTHER |
2015-09-07 |
|
Retrieval of Patient Information After Discontinuation NCT01658722 Bapineuzumab |
NA anti-amyloid-antibody |
TERMINATED | 169 | JANSSEN Alzheimer Immunotherapy Research & Development, LLC INDUSTRY |
2015-09-02 |
|
Physical Activity and Cerebral Metabolism in the Elderly: a Randomised Controlled Trial NCT02343029 Individualised aerobic exercise training; Waiting Control Runs in: Germany · 2 sites |
NA other |
COMPLETED | 60 | Professor Johannes Pantel OTHER |
2015-09-02 |
|
Vanquishing Apathy Through E-inclusion Using Realistic Virtual Environment Project NCT01798199 The training by Verve System Runs in: France · 3 sites |
NA other |
COMPLETED | 21 | Centre Hospitalier Universitaire de Nice OTHER |
2015-09-01 |
|
Usability of Virtual Reality in Subjects With Mild Cognitive Impairment or Alzheimer's Disease NCT02176629 Condition virtual reality (VR) then Condition classic cognitive sti... Runs in: France · 1 site |
NA other |
COMPLETED | 60 | Centre Hospitalier Universitaire de Nice OTHER |
2015-09-01 |
|
Perceptions Regarding Investigational Screening for Memory Problems in Primary Care NCT00759252 Runs in: United States · 1 site |
NA other |
COMPLETED | 954 | Indiana University OTHER |
2015-08-28 |
|
Families Affected by Dementia: A Survey of Caregivers NCT02095327 Runs in: United States · 1 site |
NA other |
COMPLETED | 60 | University of Miami OTHER |
2015-08-28 |
|
Study of a Strategy to Prevent Oversedation in Intensive Care Patients Under Mechanical Ventilation NCT01617265 Clinical Procedure to Prevent Oversedation; Usual sedation practice Runs in: France · 43 sites |
NA other |
COMPLETED | 1,180 | French Society for Intensive Care OTHER |
2015-08-26 |
|
Treatment of Aggression, Anger and Emotional Dysregulation in Borderline Personality Disorder NCT00467038 Dialectical Behavior Runs in: United States · 1 site |
NA other |
COMPLETED | 22 | US Department of Veterans Affairs OTHER_GOV |
2015-08-25 |
|
A Study to Test the Performance of the CogState Computerized Neuropsychological Battery in Patients With Alzheimer's Disease (0000-086)(COMPLETED) NCT00777608 Comparator: Placebo 5mg (run in); Donepezil 5 - 10 mg; Comparator: ... |
PHASE1 symptomatic-cholinergic |
COMPLETED | 106 | Merck Sharp & Dohme LLC INDUSTRY |
2015-08-25 |
|
Pilot Study of the Effects of Resveratrol Supplement in Mild-to-moderate Alzheimer's Disease NCT00743743 Longevinex brand resveratrol supplement; placebo |
PHASE3 other |
WITHDRAWN | 0 | Medical College of Wisconsin OTHER |
2015-08-24 |
|
Specific Care and Assistance Plan for Alzheimer's Disease NCT00480220 Global care and support program Runs in: France · 40 sites |
NA other |
COMPLETED | 1,200 | University Hospital, Toulouse OTHER |
2015-08-19 |
|
Actigraphic Analysis of Treatment Response NCT00723580 risperidone Runs in: United States · 1 site |
NA other |
COMPLETED | 1 | Child Psychopharmacology Institute OTHER |
2015-08-18 |
|
Mindful Awareness Program for the Prevention of Dementia: A Randomized Controlled Trial NCT02286791 Mindful Awareness Program; Health Education Program Runs in: Singapore · 1 site |
NA other |
COMPLETED | 55 | National University of Singapore OTHER |
2015-08-18 |
|
Physical Training and Cognitive Activity on the Mild Cognitive Impairment (MCI) Patient NCT01553929 Physical Training and cognitive activity (EPC group); Physical trai... Runs in: France · 1 site |
NA other |
TERMINATED | 5 | Centre Hospitalier Universitaire de Nice OTHER |
2015-08-14 |
|
Cognitive Behavior Therapy for Treating Anxiety in People With Dementia NCT00596284 Cognitive Behavioral Therapy of Anxiety in Dementia (CBT-AD); Enhan... Runs in: United States · 2 sites |
PHASE1 other |
COMPLETED | 34 | Baylor College of Medicine OTHER |
2015-08-13 |
|
A Study to Evaluate the Effect of Bexarotene on Beta-Amyloid and Apolipoprotein E Metabolism in Healthy Subjects NCT02061878 Bexarotene; Placebo Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 12 | ReXceptor, Inc. INDUSTRY |
2015-08-13 |
|
Cerebral Substrates of Prospective Memory in Young and Its Disruption in Normal Aging and in Alzheimer's Disease: A Study in Anatomical MRI, Diffusion Tensor MRI and Functional MRI NCT02522091 functional brain MRI; Neuropsychology tests Runs in: France · 1 site |
NA other |
UNKNOWN | 178 | University Hospital, Caen OTHER |
2015-08-13 |
|
A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED) NCT00757939 MRI; FDG-PET |
PHASE1 other |
COMPLETED | 40 | Merck Sharp & Dohme LLC INDUSTRY |
2015-08-11 |
|
Transcranial Direct Current Stimulation (tDCS) as a Cognitive Enhancer for Patients With Alzheimers Disease NCT02518412 tDCS; Placebo tDCS Runs in: Norway · 1 site |
NA other |
UNKNOWN | 30 | University of Tromso OTHER |
2015-08-11 |
|
Developing Violence Prevention Therapy for Substance Abusers NCT00551863 IVPT Runs in: United States · 1 site |
PHASE1|PHASE2 other |
COMPLETED | 131 | University of Michigan OTHER |
2015-08-07 |
|
The Efficacy and Safety Study of High Dose Donepezil in Parkinson's Disease With Dementia NCT02415062 Donepezil Runs in: South Korea · 1 site |
PHASE2 symptomatic-cholinergic |
UNKNOWN | 150 | Inje University OTHER |
2015-08-06 |
|
Markers of Alzheimers Disease After Propofol or Isoflurane Anesthesia NCT01640275 Propofol; Isoflurane Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 105 | Duke University OTHER |
2015-08-04 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial